---
title: "Tolvaptan - Inappropriate Adh Syndrome"
sidebar: mydoc_sidebar
permalink: db06212-mesh-d007177-1.html
toc: false 
---


Path ID: `DB06212_MESH_D007177_1`
{% include image.html url="images/db06212-mesh-d007177-1.png" file="db06212-mesh-d007177-1.png" alt="db06212-mesh-d007177-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:C116664">MESH:C116664 </a> | tolvaptan | Drug |
| <a href="https://identifiers.org/UniProt:P30518">UniProt:P30518 </a> | Vasopressin V2 receptor | Protein |
| <a href="https://identifiers.org/reactome:R-HSA-432040">reactome:R-HSA-432040 </a> | Vasopressin regulates renal water homeostasis via Aquaporins | Pathway |
| <a href="https://identifiers.org/GO:0070295">GO:0070295 </a> | renal water absorption | BiologicalProcess |
| <a href="https://identifiers.org/MESH:D007177">MESH:D007177 </a> | Inappropriate ADH Syndrome | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Tolvaptan | NEGATIVELY REGULATES | Vasopressin V2 Receptor |
| Vasopressin V2 Receptor | PARTICIPATES IN | Vasopressin Regulates Renal Water Homeostasis Via Aquaporins |
| Vasopressin Regulates Renal Water Homeostasis Via Aquaporins | POSITIVELY REGULATES | Renal Water Absorption |
| Renal Water Absorption | POSITIVELY CORRELATED WITH | Inappropriate Adh Syndrome |
|---------|-----------|---------|

Comment: This disease is also known as Syndrome of inappropriate vasopressin secretion as per the original file. Tolvaptan is also known as aquaretic (https://en.wikipedia.org/wiki/Aquaretic). Note that hyponatremia corresponds to the state where water content is relatively large for the sodium content available (https://pubmed.ncbi.nlm.nih.gov/19322975/), which is possibly due to increased water reabsorption.

Reference: 
  - [https://go.drugbank.com/drugs/DB06212#mechanism-of-action](https://go.drugbank.com/drugs/DB06212#mechanism-of-action)
  - [https://pubmed.ncbi.nlm.nih.gov/20868352/](https://pubmed.ncbi.nlm.nih.gov/20868352/)
  - [https://en.wikipedia.org/wiki/Vasopressin_receptor_antagonist](https://en.wikipedia.org/wiki/Vasopressin_receptor_antagonist)
  - [https://en.wikipedia.org/wiki/Syndrome_of_inappropriate_antidiuretic_hormone_secretion#Treatment](https://en.wikipedia.org/wiki/Syndrome_of_inappropriate_antidiuretic_hormone_secretion#Treatment)
